The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

Medically reviewed by David Ozeri, MD Complement 3 glomerulopathy (C3G) is considered a very rare disease. With C3G, patients have issues with their immune system that cause kidney damage and symptoms ...

A new study by the National Cancer Research Center (CNIO) has identified several sets of genes related to the predisposition ...

Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...

Medically reviewed by Erika Prouty, PharmD Key Takeaways There are two types of complement 3 glomerulopathy: dense deposit ...

A new study by the National Cancer Research Centre (CNIO) has identified several sets of genes related to the predisposition ...

This knowledge would help identify individuals who could benefit from early detection programmes, which are essential for a ...

In turn, the company—which is broadly seeking to develop inflammatory drugs targeting the complement system—anticipates ...

OpenAI just released a report about healthcare drawn from anonymized chatbot conversations. The title could double as one of ...

AI chatbot achieves high accuracy in performing clinical patient diagnostic interviews for common mental health disorders.

Find a portion of our conversation below, which covers Broussard’s decision to leave Humana and his thoughts on how AI could affect health care companies’ brand reputations. Editor’s Note: Transcript ...